BBNX
Beta Bionics, Inc.
Key Financials
Net Income
$-73200000
↓ 33.7%
Gross Profit
$55.5M
↑ 54.8%
Revenue
$100.3M
↑ 53.9%
Operating Income
$-71681000
↓ 58.4%
EPS (Diluted)
$-1.81
↑ 79.0%
Total Assets
$328.7M
↑ 119.7%
Shareholders' Equity
$287.6M
↑ 217.2%
Cash & Equivalents
$31.6M
↑ 3.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BBNX |
| Company Name | Beta Bionics, Inc. |
| CIK | 1674632 |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-427-7785 |